The demos in this chapter are computed inside the browser you are viewing them in (Observable JS). Move the sliders and the figures and numbers change on the spot.
WarningAbout these models
These are simplified educational models for getting a feel for the ideas in the text. Real weight change involves adaptations in energy expenditure (e.g. expenditure rises as you gain weight), so the numbers cannot be used as-is to make real-world predictions.
7.1 Demo 1: hypertrophy or hyperplasia?
We treat an adipocyte as a sphere and assume its contents are entirely triglyceride (in reality, more than 95% of an adipocyte is triglyceride (Arner 2005)). We set the density of triglyceride at about 0.92 g/mL (an assumption of this model). Dividing body fat mass by the number of adipocytes lets us compute the amount of fat per cell → volume → diameter.
The number of adipocytes in adults has been reported to be nearly constant from adulthood onwards in both lean and obese people, with about 10% renewed every year (Spalding et al. 2008). The slider range (2–15 × 10¹⁰ cells) was chosen by the author so that diameters in this model come out at roughly several tens to a little over a hundred µm.
viewof fatKg = Inputs.range([5,60], {value:15,step:1,label:"Body fat mass (kg)"})viewof cellsE10 = Inputs.range([2,15], {value:5,step:0.5,label:"Number of adipocytes (×10¹⁰ cells)"})
Keeping the cell number fixed, double the body fat mass. By what factor does the diameter change? (Hint: volume ×2, diameter ×\(2^{1/3} \approx 1.26\))
For the same body fat mass of 30 kg, how different is the mean diameter with 3×10¹⁰ cells versus 12×10¹⁰ cells? According to the ideas in Chapters 2 and 6, which carries the higher risk — someone like the former who “stores fat in few cells,” or the latter?
TipWhat to take away
Even when the diameter seems to differ only slightly, volume (= the amount of fat stored) scales with the cube of the diameter. Tissue that can add cells by hyperplasia can take up the same amount of fat while keeping the cells small. Subcutaneous progenitors accumulate lipid better and proliferate more than omental ones (Tchkonia et al. 2005), and adipocyte size predicts diabetes independently of body fat mass (Weyer et al. 2000).
7.2 Demo 2: when subcutaneous fat overflows (the expandability hypothesis)
When a fixed daily energy surplus is maintained, we compute where the added fat is stored using the following rules.
1 kg of body weight ≈ 7,700 kcal (the “3,500 kcal per pound” rule of thumb; roughly applicable to people with high body fat, but an overestimate for people with low body fat (Hall 2008))
Until the subcutaneous fat capacity (how many more kg it can store) is reached, 85% of the added fat goes to subcutaneous fat and 15% to visceral fat
After capacity is reached, 70% of the added fat goes to visceral fat and 30% to ectopic fat in the liver, etc.
The idea of a capacity ceiling is based on the expandability hypothesis (Virtue and Vidal-Puig 2010), but the 85% / 15% / 70% / 30% split consists of provisional values set by the author to convey the idea, not values from the literature.
md`Fat gained after ${years} year(s): **subcutaneous ${last[0].kg.toFixed(1)} kg / visceral ${last[1].kg.toFixed(1)} kg / ectopic ${last[2].kg.toFixed(1)} kg** (total ${(last[0].kg+last[1].kg+last[2].kg).toFixed(1)} kg)`
Try it
Keeping the energy surplus at 50 kcal/day for 5 years, lower the subcutaneous fat capacity from 25 kg to 3 kg. The total gain is the same, but how do visceral and ectopic fat change?
Which does a capacity of 3 kg most resemble: “Japanese people with little subcutaneous fat” or “older people with atrophied subcutaneous fat” from Chapter 5, or “lipodystrophy” from Chapter 6?
Increasing the capacity corresponds to the action of which drug in Chapter 6?
TipWhat to take away
Even with the same weight gain, the amounts of visceral and ectopic fat change greatly depending on subcutaneous fat capacity. This is the central claim of the expandability hypothesis: not only “how much weight you gained” but also “how much your adipose tissue can take up” governs metabolism (Virtue and Vidal-Puig 2010).
Arner, P. 2005. “Human fat cell lipolysis: biochemistry, regulation and clinical role.”Best Practice & Research. Clinical Endocrinology & Metabolism 19 (4): 471–82. https://doi.org/10.1016/j.beem.2005.07.004.
Hall, K. D. 2008. “What is the required energy deficit per unit weight loss?”International Journal of Obesity (2005) 32 (3): 573–76. https://doi.org/10.1038/sj.ijo.0803720.
Spalding, K. L., E. Arner, P. O. Westermark, et al. 2008. “Dynamics of fat cell turnover in humans.”Nature 453 (7196): 783–87. https://doi.org/10.1038/nature06902.
Tchkonia, T., Y. D. Tchoukalova, N. Giorgadze, et al. 2005. “Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots.”American Journal of Physiology. Endocrinology and Metabolism 288 (1): E267–77. https://doi.org/10.1152/ajpendo.00265.2004.
Virtue, S., and A. Vidal-Puig. 2010. “Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome–an allostatic perspective.”Biochimica Et Biophysica Acta 1801 (3): 338–49. https://doi.org/10.1016/j.bbalip.2009.12.006.
Weyer, C., J. E. Foley, C. Bogardus, P. A. Tataranni, and R. E. Pratley. 2000. “Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.”Diabetologia 43 (12): 1498–506. https://doi.org/10.1007/s001250051560.